Seminars in Oncology
Volume 31, Issue 4 , Pages 530-541 , August 2004

Imaging of esophageal and gastric cancer

  • Wolfgang A. Weber

      Affiliations

    • Department of Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany
    • Corresponding Author InformationAddress reprint requests to Wolfgang A. Weber, MD, Ahmanson Institute for Biological Imaging, UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-6942 USA
    • ,
  • Katja Ott

      Affiliations

    • Department of Surgery, Technische Universitaet Muenchen, Munich, Germany

References 

  1. Lerut T, Coosemans W, Decker G, et al.  Cancer of the esophagus and gastro-esophageal junction (Potentially curative therapies). Surg Oncol. 2001;10:113–122
  2. Stein HJ, Brucher BL, Sendler A, et al.  Esophageal cancer (Patient evaluation and pre-treatment staging). Surg Oncol. 2001;10:103–111
  3. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–543
  4. Earle CC, Maroun J, Zuraw L. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg. 2002;45:438–446
  5. Makuuchi H, Kise Y, Shimada H, et al.  Endoscopic mucosal resection for early gastric cancer. Semin Surg Oncol. 1999;17:108–116
  6. Ell C, May A, Gossner L, et al.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118:670–677
  7. Lowy AM, Mansfield PF, Leach SD, et al.  Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg. 1999;229:303–308
  8. Ancona E, Ruol A, Santi S, et al.  Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma (Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone). Cancer. 2001;91:2165–2174
  9. Prokop M. General principles of MDCT. Eur J Radiol. 2003;45(suppl 1):S4–S10
  10. Fenchel S, Fleiter TR, Merkle EM. Multislice helical CT of the abdomen. Eur Radiol. 2002;12(suppl 2):S5–S10
  11. Di Simone MP, Mattioli S, D’Ovidio F, et al.  Three-dimensional CT imaging and virtual endoscopy for the placement of self-expandable stents in oesophageal and tracheobronchial neoplastic stenoses. Eur J Cardiothorac Surg. 2003;23:106–108
  12. Byrne MF, Jowell PS. Gastrointestinal imaging (Endoscopic ultrasound). Gastroenterology. 2002;122:1631–1648
  13. Murata Y, Ohta M, Hayashi K, et al.  Preoperative evaluation of lymph node metastasis in esophageal cancer. Ann Thorac Cardiovasc Surg. 2003;9:88–92
  14. Murata Y, Napoleon B, Odegaard S. High-frequency endoscopic ultrasonography in the evaluation of superficial esophageal cancer. Endoscopy. 2003;35:429–435
  15. Phelps ME. Inaugural article (Positron emission tomography provides molecular imaging of biological processes). Proc Natl Acad Sci USA. 2000;97:9226–9233
  16. Flier JS, Mueckler MM, Usher P, et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 1987;235:1492–1495
  17. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging (Physiologic and benign variants). Radiographics. 1999;19:61–77
  18. Flamen P, Lerut A, Van Cutsem E, et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–3210
  19. Kim K, Park SJ, Kim BT, et al.  Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg. 2001;71:290–294
  20. Stahl A, Ott K, Weber WA, et al.  FDG PET imaging of locally advanced gastric carcinomas (Correlation with endoscopic and histopathological findings). Eur J Nucl Med Mol Imaging. 2003;30:288–295
  21. Kawamura T, Kusakabe T, Sugino T, et al.  Expression of glucose transporter-1 in human gastric carcinoma (Association with tumor aggressiveness, metastasis, and patient survival). Cancer. 2001;92:634–641
  22. Kumbasar B. Carcinoma of esophagus (Radiologic diagnosis and staging). Eur J Radiol. 2002;42:170–180
  23. Giovagnoni A, Valeri G, Ferrara C. MRI of esophageal cancer. Abdom Imaging. 2002;27:361–366
  24. Motohara T, Semelka RC. MRI in staging of gastric cancer. Abdom Imaging. 2002;27:376–383
  25. Natsugoe S, Yoshinaka H, Shimada M, et al.  Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg. 1999;229:62–66
  26. Adachi Y, Sakino I, Matsumata T, et al.  Preoperative assessment of advanced gastric carcinoma using computed tomography. Am J Gastroenterol. 1997;92:872–875
  27. Stell DA, Carter CR, Stewart I, et al.  Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg. 1996;83:1260–1262
  28. Botet JF, Lightdale CJ, Zauber AG, et al.  Preoperative staging of esophageal cancer (comparison of endoscopic US and dynamic CT). Radiology. 1991;181:419–425
  29. Block MI, Patterson GA, Sundaresan RS, et al.  Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg. 1997;64:770–776
  30. Luketich JD, Friedman DM, Weigel TL, et al.  Evaluation of distant metastases in esophageal cancer (100 consecutive positron emission tomography scans). Ann Thorac Surg. 1999;68:1133–1136
  31. Downey RJ, Akhurst T, Ilson D, et al.  Whole body 18FDG-PET and the response of esophageal cancer to induction therapy (results of a prospective trial). J Clin Oncol. 2003;21:428–432
  32. Lerut T, Flamen P, Ectors N, et al.  Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction (A prospective study based on primary surgery with extensive lymphadenectomy). Ann Surg. 2000;232:743–752
  33. Kinkel K, Lu Y, Both M, et al.  Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET) (A meta-analysis). Radiology. 2002;224:748–756
  34. De Potter T, Flamen P, Van Cutsem E, et al.  Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002;29:525–529
  35. Tschmelitsch J, Weiser MR, Karpeh MS. Modern staging in gastric cancer. Surg Oncol. 2000;9:23–30
  36. Yoshioka T, Yamaguchi K, Kubota K, et al.  Evaluation of 18F-FDG PET in patients with a, metastatic, or recurrent gastric cancer. J Nucl Med. 2003;44:690–699
  37. Kelly S, Harris KM, Berry E, et al.  A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49:534–539
  38. Harris KM, Kelly S, Berry E, et al.  Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. Health Technol Assess. 1998;2:1–134
  39. Meining A, Dittler HJ, Wolf A, et al.  You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut. 2002;50:599–603
  40. D’Elia F, Zingarelli A, Palli D, et al.  Hydro-dynamic CT preoperative staging of gastric cancer (Correlation with pathological findings. A prospective study of 107 cases). Eur Radiol. 2000;10:1877–1885
  41. Sohn KM, Lee JM, Lee SY, et al.  Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol. 2000;174:1551–1557
  42. Kato H, Kuwano H, Nakajima M, et al.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–928
  43. Kienle P, Buhl K, Kuntz C, et al.  Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion. 2002;66:230–236
  44. Romagnuolo J, Scott J, Hawes RH, et al.  Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc. 2002;55:648–654
  45. Wakelin SJ, Deans C, Crofts TJ, et al.  A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol. 2002;41:161–167
  46. Hunerbein M, Ulmer C, Handke T, et al.  Endosonography of upper gastrointestinal tract cancer on demand using miniprobes or endoscopic ultrasound. Surg Endosc. 2003;17:615–619
  47. Wu LF, Wang BZ, Feng JL, et al.  Preoperative TN staging of esophageal cancer (comparison of miniprobe ultrasonography, spiral CT and MRI). World J Gastroenterol. 2003;9:219–224
  48. Yoon YC, Lee KS, Shim YM, et al.  Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma (CT versus FDG PET for presurgical detection prospective study). Radiology. 2003;227:764–770
  49. Pieterman RM, van Putten JW, Meuzelaar JJ, et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254–261
  50. Kelsen DP, Ginsberg R, Pajak TF, et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979–1984
  51. MRC Oesophageal Cancer Working Group . Surgical resection with or without preoperative chemotherapy in oesophageal cancer (A randomised controlled trial). Lancet. 2002;359:1727–1733
  52. Walsh TN, Noonan N, Hollywood D, et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467
  53. Bosset JF, Gignoux M, Triboulet JP, et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161–167
  54. Urba SG, Orringer MB, Turrisi A, et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–313
  55. Zuccaro G, Rice TW, Goldblum J, et al.  Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol. 1999;94:906–912
  56. Beseth BD, Bedford R, Isacoff WH, et al.  Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg. 2000;66:827–831
  57. Laterza E, de Manzoni G, Guglielmi A, et al.  Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg. 1999;67:1466–1469
  58. Law S, Fok M, Chow S, et al.  Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus (A prospective randomized trial). J Thorac Cardiovasc Surg. 1997;114:210–217
  59. Miller AB, Hoogstraten B, Staquet M, et al.  Reporting results of cancer treatment. Cancer. 1981;47:207–214
  60. Willis J, Cooper GS, Isenberg G, et al.  Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc. 2002;55:655–661
  61. Chak A, Canto MI, Cooper GS, et al.  Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer. 2000;88:1788–1795
  62. Brucher BL, Weber W, Bauer M, et al.  Neoadjuvant therapy of esophageal squamous cell carcinoma (Response evaluation by positron emission tomography). Ann Surg. 2001;233:300–309
  63. Flamen P, Van Cutsem E, Lerut A, et al.  Positron emission tomography for assessment of the response to induction chemotherapy in locally advanced esophageal cancer. Ann Oncol. 2002;13:361–368
  64. Weber WA, Ott K, Becker K, et al.  Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol. 2001;19:3058–3065
  65. Ott K, Fink U, Becker K, et al.  Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging (Results of a prospective trial). J Clin Oncol. 2003;21:4604–4610
  66. Poneros JM, Brand S, Bouma BE, et al.  Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001;120:7–12
  67. Kitagawa Y, Kitajima M. Gastrointestinal cancer and sentinel node navigation surgery. J Surg Oncol. 2002;79:188–193
  68. Lardinois D, Weder W, Hany TF, et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–2507

PII: S0093-7754(04)00237-4

doi: 10.1053/j.seminoncol.2004.04.016

Seminars in Oncology
Volume 31, Issue 4 , Pages 530-541 , August 2004

Article Tools

* Image Usage & Resolution